Company Filing History:
Years Active: 2020-2021
Title: The Innovative Contributions of Matthew D. Rifat
Introduction
Matthew D. Rifat is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmacogenetics, holding a total of 3 patents. His work focuses on methods for extracting and preparing biological samples for analysis, which are crucial for advancements in personalized medicine.
Latest Patents
Rifat's latest patents include a method for extracting pharmacogenetic DNA from biological fluid retained in a solid resin collection device. This innovative method involves several steps, including sonicating the dried blood and solid resin, transferring contents to a solid resin spin column, and processing the samples through advanced techniques such as Next-Generation Sequencing and mass spectrometry-based sequencing. Another significant patent is for the preparation of a dried blood sample for multiplexing of analytes. This method allows for the efficient mixing of an Internal Standard solution with dried blood samples, enabling the analysis of multiple analytes with minimal blood volume.
Career Highlights
Matthew D. Rifat is currently employed at Alcala Pharmaceutical, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work is instrumental in enhancing the accuracy and efficiency of pharmacogenetic testing.
Collaborations
Rifat collaborates with talented professionals in his field, including David J. Smith and Christian Tagwerker. These collaborations foster a creative environment that drives innovation and research.
Conclusion
Matthew D. Rifat's contributions to pharmacogenetics through his patents and work at Alcala Pharmaceutical, Inc. highlight his commitment to advancing medical science. His innovative methods are paving the way for more effective and personalized healthcare solutions.